Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause
NCT ID: NCT00238732
Last Updated: 2007-12-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
650 participants
INTERVENTIONAL
2005-10-31
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bazedoxifene/Conjugated Estrogen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intact uterus
* At least 1 moderate to severe vulvar/vaginal symptom that is most bothersome
Exclusion Criteria
* Thrombophlebitis, thrombosis or thromboembolic disorders
* Neuro-ocular disease
40 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Wyeth is now a wholly owned subsidiary of Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Montgomery, Alabama, United States
Scottsdale, Arizona, United States
Tucson, Arizona, United States
Oakland, California, United States
San Diego, California, United States
Upland, California, United States
Denver, Colorado, United States
Avon, Connecticut, United States
Groton, Connecticut, United States
Waterbury, Connecticut, United States
Aventura, Florida, United States
Gainesville, Florida, United States
Miami, Florida, United States
Palm Harbor, Florida, United States
Palm Springs, Florida, United States
Pinnellas Park, Florida, United States
Stuart, Florida, United States
Tampa, Florida, United States
West Palm Beach, Florida, United States
Atlanta, Georgia, United States
Conyers, Georgia, United States
Douglasville, Georgia, United States
Savannah, Georgia, United States
Idaho Falls, Idaho, United States
Champaign, Illinois, United States
Chicago, Illinois, United States
Kansas City, Kansas, United States
Shreveport, Louisiana, United States
Baltimore, Maryland, United States
Ann Arbor, Michigan, United States
Booklyn Center, Minnesota, United States
Chaska, Minnesota, United States
Jackson, Mississippi, United States
Kansas, Mississippi, United States
Creve Cour, Missouri, United States
St Louis, Missouri, United States
Lebanon, New Hampshire, United States
Livingston, New Jersey, United States
New Brunswick, New Jersey, United States
Winston-Salem, North Carolina, United States
Fargo, North Dakota, United States
Jamestown, North Dakota, United States
Cincinnati, Ohio, United States
Columbus, Ohio, United States
Toledo, Ohio, United States
Oklahoma City, Oklahoma, United States
Medford, Oregon, United States
Erie, Pennsylvania, United States
Media, Pennsylvania, United States
West Reading, Pennsylvania, United States
Hilton Head Island, South Carolina, United States
Sioux Falls, South Dakota, United States
Nashville, Tennessee, United States
Dallas, Texas, United States
Denton, Texas, United States
Galveston, Texas, United States
San Antonio, Texas, United States
Salt Lake City, Utah, United States
Burlington, Vermont, United States
Norfolk, Virginia, United States
Richmond, Virginia, United States
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lara LA, Cartagena-Ramos D, Figueiredo JB, Rosa-E-Silva ACJ, Ferriani RA, Martins WP, Fuentealba-Torres M. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2023 Aug 24;8(8):CD009672. doi: 10.1002/14651858.CD009672.pub3.
Pinkerton JV, Bushmakin AG, Komm BS, Abraham L. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning. Maturitas. 2017 Jun;100:57-63. doi: 10.1016/j.maturitas.2017.03.315. Epub 2017 Mar 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3115A1-306
Identifier Type: -
Identifier Source: org_study_id